Copyright
©The Author(s) 2015.
World J Gastrointest Pathophysiol. Nov 15, 2015; 6(4): 90-98
Published online Nov 15, 2015. doi: 10.4291/wjgp.v6.i4.90
Published online Nov 15, 2015. doi: 10.4291/wjgp.v6.i4.90
Table 1 Randomized controlled trials evaluating the treatment of alcoholic hepatitis
| Study | Topic | Methods | Findings |
| Prednisolone or pentoxifylline | |||
| Theodossi et al[99] | PRED vs placebo | Randomized control | No difference in mortality |
| Ramond et al[100] | PRED vs placebo | Double-blinded, randomized control | Improved mortality with PRED |
| Akriviadis et al[69] | PTX vs placebo | Double-blinded, randomized control | Improved mortality with PTX |
| Sidhu et al[101] | PTX vs placebo | Randomized control | Improved mortality with PTX |
| De et al[102] | PTX vs PRED | Double-blinded, randomized control | Reduced mortality with PTX |
| Park et al[103] | PTX vs PRED | Randomized control | Reduced mortality with PRED |
| Mathurin et al[104] | PRED vs PRED + PTX | Multicenter, double-blinded, randomized control | No difference in mortality |
| De et al[105] | PTX vs PTX + PRED | Double-blinded, randomized control | No difference in mortality |
| Thursz et al[70] | PTX vs PRED vs placebo | Multicenter, double-blinded, randomized control | No difference in mortality |
| N-acetylcysteine | |||
| Moreno et al[106] | NAC vs placebo | Multicenter, single-blinded, randomized control | No difference in mortality |
| Cytokine inhibitors | |||
| Naveau et al[72] | Infliximab vs placebo | Double-blinded, randomized control | Increased mortality with infliximab |
| Boetticher et al[71] | Etancercept vs placebo | Multicenter, single-blinded, randomized control | Increased mortality with etancercept |
- Citation: Suraweera DB, Weeratunga AN, Hu RW, Pandol SJ, Hu R. Alcoholic hepatitis: The pivotal role of Kupffer cells. World J Gastrointest Pathophysiol 2015; 6(4): 90-98
- URL: https://www.wjgnet.com/2150-5330/full/v6/i4/90.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v6.i4.90
